GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (HAM:MYD) » Definitions » Momentum Rank

Myriad Genetics (HAM:MYD) Momentum Rank : 5 (As of Dec. 11, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Myriad Genetics Momentum Rank?

Myriad Genetics has the Momentum Rank of 5.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Myriad Genetics's Momentum Rank

For the Diagnostics & Research subindustry, Myriad Genetics's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Myriad Genetics's Momentum Rank Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Myriad Genetics's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Myriad Genetics's Momentum Rank falls into.


Myriad Genetics Momentum Rank Related Terms

Thank you for viewing the detailed overview of Myriad Genetics's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Myriad Genetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (HAM:MYD) » Definitions » Momentum Rank
Comparable Companies
CDNA OPK CSTL NEO GRAL FLGT TWST ACRS ATLN PSNL TMO DHR XSWX:LONN A IQV IDXX MTD ILMN WAT NTRA
Traded in Other Exchanges
MYGN:USA 0K3W:UK MYD:Germany MYD:Germany
Address
320 Wakara Way, Salt Lake City, UT, USA, 84108
Website
https://www.myriad.com
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.